that enough monkeys are available to produce such a vaccine in the necessary quantities. I might add that the two primary factors that caused us 4-1~ to develop the living avianized rabies vaccine were (1) we were not able to develop a satisfactory method of freeing brain tissue vaccines of the factor or factors responsible for producing allergic encephalitis and still retain a stable and potent product, and (2) we wished to provide longer-lasting protection than that usually afforded by killed vaccine. Common sense dictates that we should profit somewhat at least from the sad experiences we have had with rabies vaccines prepared from nervous tissues and not risk inducing the same paralytic accidents with a vaccine for poliomyelitis.
Recent advances in the field bear great promise that, in the foreseeable future, a method will be developed by which we can produce a statisfactory vaccine for protection against poliomyelitis. One of these developments is the work of Enders and his associates, 11-19 who first showed that it is possible to grow all three types of poliomyelitis virus in cultures of non-neural tissues of human origin. This procedure, of course, obviates the risk of causing allergic encephalitis since non-nervous tissues such as kidney, uterus, or muscle are used. This approach for solving various aspects of the poliomyelitis problem, such as virus detection, propagation, assay, antibody quantitation, and preparation of diagnostic antigens and of vaccines has been pursued by numerous workers in the field, including Salk and his associates at the University of Pittsburgh, 2~ Melnick at Yale, 23-27 Syverton at the University of Minnesota, 2s-32 Rhodes at the University of Toronto, [33] [34] [35] and Evans at the Univeristy of Washington. 36 ' 37 At this time, I wish to point out that any vaccine prepared from tissue cultures that contain mammalian cells taken at surgery or from sacrificed animals must of necessity be a killed vaccine. Because of the inherent danger of picking up extraneous contaminant viral, rickettsial, bacterial, or carcinogenic agents, it would be unwise and impractical for anyone charged with the responsibility of commercial vaccine production to assume the risk of producing a living, modified virus vaccine from explanted tissues derived from a mammalian source.
Recently, Salk 38 reported preliminary experiments in which he vaccinated approximately 161 human volunteers with formalin-killed virus vaccines prepared from tissue culture materials using either minced monkey kidney or monkey testicle. He found that, if given intradermally as an aqueous preparation, the vaccine induced an antibody response only against the Lansing Type 2 virus.
A water-in-mineral-oil emulsion type of killed vaccine prepared from all three types of poliomyelitis virus (Brunhilde, Lansing, and Leon) was claimed to induce antibody response against all three types when the vaccine was administered intramuscularly. The antibody levels of the vaccinated subjects were determined by tissue culture technique.
It should be noted, however, that all antibody titers reported were from sera taken a very short time after vaccination, that is, not longer than four to seven weeks postvaccination. Furthermore, significant antibody levels were found in most of the people prior to vaccination, namely, in 6 of 12 against Type 2, 7 of 16 against Type 3, and all 15 of 15 against Type 1 poliomyelitis virus. It must be realized, of course, that it is much easier to demonstrate the antigenic booster effect or anamnestic response to an antigen by vaccinating individuals who have had a previous experience (immunizing infection) with the antigen than it is to stimulate antibody production in persons who have never had any previous exposure to the agent. Thus critically reviewed, Salk's results are not too impressive.
Salk also indicated that mineral oil adjuvant was necessary to make the issue culture virus antigens become immunogenic, and that vegetable oils could not be used as a substitute for mineral oils. 39 It is difficult at the moment to evaluate fully Salk's results for many of his experiments were not completed when his report was published. However, I believe it is not out of order to utter a word of caution about certain potential complications that may arise from such a vaccine preparation. While animal experiments have failed to demonstrate any carcinogenic action of certain highly refined paraffinic mineral oils, 4~ especially Russian or Pennsylvania oils, which are essentially free of aromatic compounds, 41 there is always the possibility that malignant tumors might occur in particularly susceptible individuals. Furthermore, it should be remembered that mineral oils are not saponifiable, and that they behave essentially as a foreign body in the tissues of the host. They are not hydrolyzed, but remain unchanged and physiologically inert for long periods of time, probably for life, regardless of how administered. The reactions to such oils have been described as foreign body granulomata, benign oil tumors, oleomas, or oil cysts, which sometimes result in slow-healing abscessesY ' 43 It should be noted that the surest way apparently to determine carcinogenicity of an oil is to inject it into a large number of mice, rats, and rabbits intramuscularly, once a month for at least three months, and observe the animals for the rest of their natural lives. In extensive experiments by this procedure, Hueper 44 has demonstrated sarcoma formation with oils that were entirely noncarcinogenic when applied to the skin. It is evident that it would be most difficult, if not impossible, for a commerical biological laboratory to carry out such tests on each and every lot, or production batch, of oil used for vaccine preparation. Yet, no one can deny the fact that such tests should be carried out if the product is to be considered safe.
In any case, the oils remain in the tissues for years, and in individuals who
give an extensive foreign body response, surgical removal of the tumors may be required. It is possible that killed vaccines that contain mineral oil as an adjuvant will give stronger and longer-lasting immunity than killed vaccines in an aqueous
base, yet it is most doubtful that either will give as long-lasting immunity as will a living, attenuated virus vaccine.
It probably will be necessary to revaccinate with the killed vaccines every two to three years in order to maintain the desired state of protection. When one considers that the product will be used primarily in young children and that the mineral oil component of each injection may persist in the tissues for life, it at once emphasizes the need to proceed with caution. Any procedure that requires repeated vaccinations over the years greatly increases the chances of sensitizing the individual to foreign proteins injected and cannot be considered as the ideal solution to the problem at hand.
In other words, the mineral-oil-adjuvant vaccine approach may be a safe procedure, but that can be proved only over a long period of time and should be determined only with a limited number of vaccinated persons. Certainly, it will take much more time to evaluate the safety of a mineral-oil-adjuvant-type vaccine than it will a living, attenuated virus vaccine. It would prove to be most embarrassing to have a situation develop comparable to that encountered with killed rabies brain tissue vaccines by which the vaccination procedure actually causes a greater number of deaths or unfortunate sequelae than occur among the unvaccinated who have been exposed similarly. 45 ' 46 Another approach toward solving the problem is to secure in tissue culture a pure line strain of normal mammalian cells, either human or animal in origin, proven to be free of any extraneous viral or bacterial contaminants and known to possess no carcinogenic activity. If it were possible to maintain such a pure line strain of normal cells in tissue culture and to propagate the cells in large enough quantities to meet our research and production needs, we would have a very useful medium. Unfortunately, at the moment we do not have the necessary information to accomplish this task, but the problem is worthy of a great deal of attention and energy.
By using a stable strain of human malignant epithelial cells (H61a strain),
derived from an epidermoid carcinoma of the cervix, for the cultivation of all three types of poliomyelitis viruses, Syverton and his associates 32' 47 have been able to quantitate antibodies by the neutralization technique to produce virus in quantity in serial passage and to isolate and type viruses rapidly. This is a significant contribution, but it is indeed unfortunate that the H61a strain is of neoplastic origin. Of course, it would be the medial discovery of the century if it were found that a chemically inactivated poliomyelitis vaccine prepared from tissue culture cells of the H61a type was carcinogenic, but that potential danger must be considered. Thus, at the moment at least, it is more doubtful that anyone would recommend the use of neoplastic cells in tissue culture as the medium for producing poliomyelitis vaccine.
Before proceeding, I wish to emphasize that the tissue culture technique is an extremely important tool, especially for research purposes, for which it can be applied to so many problems, such as isolation, identification, and propagation Returning to the problem at hand, namely, poliomyelitis, a review of the literature indicates that the two most promising paths for inducing immunity are the intramuscular and oral routes. Further, evidence obtained in the use of *By the standards of a tissue culture specialist, his method is comparatively crude, but Frenkel has introduced some very ingenious time-and labor-saving devices that give a practical tissue culture medium for producing foot-and-mouth vaccine against at least three immunologically distinct types of the virus (European A, O, and C types), using explanted epithelial tissue of the bovine rumen or tongue. Frenkel's problem has been somewhat simplified in that maximal growth of the virus (titers of 10 4 or greater) is obtained within 18 to 24 hours. This, of course, greatly facilitates the suppression of bacterial contaminants by using antibiotics or sulfonamides. Frenkel's final product is a formalinkilled vaccine. Boynton used swine bone marrow or other swine tissue explants suspended in suitable physiological media. The hog cholera virus was presumably attenuated for swine by prolonged passage in tissue culture and is not produced commercially. The product recommended for field use consists of simultaneous injections of living virus propagated in tissue culture and immune serum, thus indicating that the cultured virus may be partially, but not completely, modified in its virulence for swine.
other living virus vaccines strongly indicates the importance of using the natural portal of entry whenever possible to achieve maximal beneficial effects of the immunizing agent.
We now recognize that large epidemics of paralytic poliomyelitis in certain countries are apparently a reflection of improvement in sanitary conditions. By improving our living habits, we have altered or upset nature's balance so that, instead of having a symbiotic relationship between the host and the infectious agent, we actually have created a nonimmune population in which large epidemics of paralytic poliomyelitis can be expected and do occur. In those parts of the world that have not improved their living and sanitary habits, poliomyelitis epidemics are apparently rare and relatively unimportant, and paralysis, when it does occur, is almost always limited to children of file younger age groups.
As the virus is very widely distributed in these so-called underprivileged areas, most people come in contact with it while they are quite young and progressively acquire their immunity, in all probability, through infection by way of the oral and gastrointestinal routes, so that paralytic poliomyelitis in these countries is comparatively rare. ~ I am of the opinion that probably the most logical and practical way to immunize infants and children against poliomyelitis is to follow the pattern that seems to take place so universally under natural conditions, that is, to use an attenuated, living virus under biologically and quantitatively controlled conditions by a natural portal of entry--the oral route. I believe that the poliomyelitis problem would be greatly simplified if the developing chick embryo could be used as the propagating medium since it has proved to be so nearly the ideal host for mass producing many other living attenuated viral vaccines, such as yellow fever, smallpox, rabies, blue tongue of sheep, rinderpest, Rift Valley fever, Newcastle disease, canine distemper, fowl pox, pigeon pox, and infectious laryngotracheitis of fowls, and killed viral and rickettsial vaccines, such as Rocky Mountain spotted fever; epidemic and murine typhus fever; Q fever; influenza; mumps; Western, Eastern, and Venezuelan equine encephalomyelitis; and Japanese B encephalitis. 6~ The chick embryo possesses the admirable qualities of always being readily available, easily handled, relatively cheap, and, above all, free from microorganisms potentially dangerous for man. Furthermore, the chick embryo has a marked advantage in that it is not a natural host for poliomyelitis virus, and if a mutant strain can be established, there is very little likelihood it will regain its virulence for man. Table II shows the results obtained when chimpanzees were inoculated either orally with 5 ml each or intramuscularly with 2 ml each of chick embryo vaccine A17. None of the chimpanzees showed any ill effects following vaccination.
Blood samples were collected and tested for neutralizing antibodies on the days indicated. Chick embryo vaccine A17 showed a mouse titer of 10 -~s LDs0. Neutralization tests were carried out with homologous MEF1 virus of the 131st hamster passage. The dosages used for vaccination were considered to be practical quantities for human inoculation. On the 127th day postvaccination, all four chimpan- zees were revaccinated orally with 5 ml each of the same vaccine. It is seen that the two chimpanzees initially inoculated orally gave as good neutralization titers, if not better, than those initially injected intramuscularly. The two chimpanzees initially injected intramuscularly showed a good rise in antibody titer following their oral reinoculation on the 127th day.
As stated previously, the data presented are by necessity preliminary in nature, but they are indicative of the general trend of our studies.
In summary, I wish to emphasize that no one, at the present time, can predict when a practical and satisfactory vaccine will become available for use. To attempt to make such a prediction at this time would be folly because a tremendous amount of work yet remains to be done. However, the tools for accurate, quantitative work are now available to accomplish the task. My colleagues and I are more confident than ever that eventually all three major types of poliomyelitis virus will be grown in the developing chick embryo. We believe that a living, attenuated virus vaccine, comprised of all three major types of poliomyelitis virus propagated in chick embryos and administered by the oral route, offers the most hopeful, practical, and safe procedure to follow for the immunization of children.
